FDA’s McClellan Touts Scientific Analysis As Part Of Ephedra Ban

FDA Commissioner Mark McClellan, MD/PhD, said the "framework" for the outright ban of ephedra will be based on substantive scientific evidence as the agency prepares to publish the reg